Companies in #Refractive Disorders
Found 1 company operating in this sector.
LENZ Therapeutics is a commercial-stage biopharmaceutical company based in San Diego, California, dedicated to developing and commercializing transformative ophthalmic therapies, led by VIZZ (aceclidine ophthalmic solution 1.44%), the first and only aceclidine-based eye drop for the treatment of presbyopia. In October 2026, LENZ initiated a corporate reorganization reducing workforce headcount by 75% (~120 roles) down to ~40 employees to focus capital on direct-to-consumer digital marketing and telehealth distribution while lowering projected 2027 OPEX by over 50%.